Analyst Ratings for Globus Medical (GMED)
GMED Rating Summary
GMED Price Target Summary
- Highest: $79.00 (Canaccord Genuity)
- Lowest: $53.00 (Morgan Stanley)
- Average: $64.88
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$64.88 (+28.6%)
* Over Last 12-Mos
Rating Score: 5.9 / 10
Percentile Rank: 64%
Avg. $ Target:
$64.88 (+28.6%)
* Over Last 12-Mos
Rating Score: 5.9 / 10
Percentile Rank: 64%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 3/18/2024 | BTIG | Ryan Zimmerman | Upgrade | Buy (Neutral) |
60.00 (N/A) |
51.40 (50.45) |
-1.85% | Details |
| 10/20/2023 | Roth/MKM | Jason Wittes | New Coverage | Buy (N/A) |
75.00 (N/A) |
53.88 (50.45) |
-6.37% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
